General Information of Drug (ID:
DR5283) |
Drug Name |
Prinomastat
|
Synonyms |
AG-3354; AG-3362; Prinomastat (USAN/INN); (3S)-N-hydroxy-2,2-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylthiomorpholine-3-carboxamide |
Indication |
Lung cancer
[ICD11: 2C25]
|
Approved
|
[1]
|
Brain cancer
[ICD11:
ICD11: 2A00]
|
Discontinued in Phase 3
|
[2]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
423.5 |
Topological Polar Surface Area |
143 |
Heavy Atom Count |
28 |
Rotatable Bond Count |
5 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
8 |
Cross-matching ID |
- PubChem CID
- 466151
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D00MDP
- Formula
- C18H21N3O5S2
- Canonical SMILES
- CC1([C@@H](N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OC3=CC=NC=C3)C(=O)NO)C
- InChI
- InChI=1S/C18H21N3O5S2/c1-18(2)16(17(22)20-23)21(11-12-27-18)28(24,25)15-5-3-13(4-6-15)26-14-7-9-19-10-8-14/h3-10,16,23H,11-12H2,1-2H3,(H,20,22)/t16-/m0/s1
- InChIKey
- YKPYIPVDTNNYCN-INIZCTEOSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.